| 1 |
29434827 | Anti-inflammatory drug resistance selects putative cancer stem cells in a cellular model for genetically predisposed colon cancer. | 2018 Jan |
1 |
| 2 |
23327547 | Selenium and sulindac are synergistic to inhibit intestinal tumorigenesis in Apc/p21 mice. | 2013 Jan 17 |
1 |
| 3 |
21403839 | Intervening in β-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis. | 2011 Feb |
5 |
| 4 |
20716632 | Molecular alterations associated with sulindac-resistant colon tumors in ApcMin/+ mice. | 2010 Sep |
2 |
| 5 |
21041628 | Chemoprevention by nonsteroidal anti-inflammatory drugs eliminates oncogenic intestinal stem cells via SMAC-dependent apoptosis. | 2010 Nov 16 |
2 |
| 6 |
12584176 | Suppression of tumorigenesis in the Apc(min) mouse: down-regulation of beta-catenin signaling by a combination of tea plus sulindac. | 2003 Feb |
4 |
| 7 |
12351151 | Response of Apc(min) and A33 (delta N beta-cat) mutant mice to treatment with tea, sulindac, and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). | 2002 Sep 30 |
5 |
| 8 |
11245490 | Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. | 2001 Feb 15 |
1 |
| 9 |
10223192 | Relationship of beta-catenin and Bcl-2 expression to sulindac-induced regression of intestinal tumors in Min mice. | 1999 Apr |
1 |